Squarepoint
FLGT icon

Squarepoint’s Fulgent Genetics FLGT Stock Holding History

Squarepoint’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52,534
Closed -$835K – 4611
2026
Q1 		$835K Sell
52,534
-3,668
-7% -$79.6K ﹤0.01% 2932
2025
Q4 		$1.48M Buy
56,202
+6,915
+14% +$179K ﹤0.01% 2284
2025
Q3 		$1.11M Buy
49,287
+22,809
+86% +$470K ﹤0.01% 2601
2025
Q2 		$526K Sell
26,478
-60,707
-70% -$1.18M ﹤0.01% 3231
2025
Q1 		$1.47M Buy
87,185
+45,577
+110% +$776K ﹤0.01% 2325
2024
Q4 		$769K Buy
41,608
+26,659
+178% +$520K ﹤0.01% 3319
2024
Q3 		$325K Buy
+14,949
New +$334K ﹤0.01% 3392
2023
Q3 		– Sell
-45,664
Closed -$1.69M – 3932
2023
Q2 		$1.69M Buy
+45,664
New +$1.59M 0.01% 1772
2022
Q1 		– Sell
-9,143
Closed -$920K – 3072
2021
Q4 		$920K Sell
9,143
-5,357
-37% -$471K ﹤0.01% 1750
2021
Q3 		$1.3M Sell
14,500
-6,328
-30% -$575K ﹤0.01% 1414
2021
Q2 		$1.92M Buy
+20,828
New +$1.66M 0.01% 1206
2021
Q1 		– Sell
-6,278
Closed -$327K – 3272
2020
Q4 		$327K Sell
6,278
-7,426
-54% -$310K ﹤0.01% 2139
2020
Q3 		$549K Sell
13,704
-7,442
-35% -$233K 0.01% 1369
2020
Q2 		$338K Buy
+21,146
New +$324K 0.01% 1533

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's FLGT Position: Q2 2026 in Review

Squarepoint sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 52,534 shares — an estimated $835K sold.

Squarepoint first reported a position in FLGT in Q2 2020 and held it in 14 quarters. The position peaked at $1.92M in Q2 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Squarepoint reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 52,534 Fulgent Genetics shares in Q2 2026, an estimated $835K.
  • Squarepoint first reported a position in Fulgent Genetics in Q2 2020 and held it in 14 quarters.
  • Squarepoint's Fulgent Genetics position peaked at $1.92M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.